TY - JOUR
T1 - Regulation of fructose 2,6-P2 concentration in isolated hepatocytes
AU - Richards, Carolyn Sue
AU - Furuya, Eisuke
AU - Uyeda, Kosaku
N1 - Funding Information:
This work was supported
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1981/6/30
Y1 - 1981/6/30
N2 - The effect of hormones on fructose-2,6-P2 level and fructose-6-P,2-kinase activity was examined using rat hepatocytes. The dose response curve shows the half-maximal effect of glucagon on fructose-2,6-P2 occurs at 3 X 10-13 M glucagon, whereas the half-maximal effect on cyclic AMP occurs at 3 × 10-0 M. The decrease in fructose-2,6-P2 parallels the decrease in fructose-6-P,2-kinase activity. Incubation of cells with dibutryl cyclic AMP and cyclic AMP results in a 2- to 3-fold decrease in fructose-2,6-P2. Epinephrine (10-5 M) mediates a 2-fold decrease in fructose-2,6-P2; isoproterenol has no effect. These results suggest that regulation of fructose-6-P,2-kinase is complex, involving cyclic AMP-dependent and -independent mechanisms.
AB - The effect of hormones on fructose-2,6-P2 level and fructose-6-P,2-kinase activity was examined using rat hepatocytes. The dose response curve shows the half-maximal effect of glucagon on fructose-2,6-P2 occurs at 3 X 10-13 M glucagon, whereas the half-maximal effect on cyclic AMP occurs at 3 × 10-0 M. The decrease in fructose-2,6-P2 parallels the decrease in fructose-6-P,2-kinase activity. Incubation of cells with dibutryl cyclic AMP and cyclic AMP results in a 2- to 3-fold decrease in fructose-2,6-P2. Epinephrine (10-5 M) mediates a 2-fold decrease in fructose-2,6-P2; isoproterenol has no effect. These results suggest that regulation of fructose-6-P,2-kinase is complex, involving cyclic AMP-dependent and -independent mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0019521739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019521739&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(81)90711-7
DO - 10.1016/0006-291X(81)90711-7
M3 - Article
C2 - 6271128
AN - SCOPUS:0019521739
SN - 0006-291X
VL - 100
SP - 1673
EP - 1679
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 4
ER -